Three Top Anti-Aging Interventions Go Head-to-Head: Can Rapamycin Reshape Immune Aging? A Study of 80 Beagles Decodes Immune Senescence Within Their Short Lifespans
52.58 million pet dogs and 76 million dog owners — these are China’s pet dog statistics for 2024[1]. For many people, dogs are far more than pets. They greet you at the door after a long day, curl up beside you when you feel down, and are beloved members of the family. Yet within aging biology research, they hold another vital role: a translational aging model bridging mouse studies and human research. Unlike mixed-breed companion dogs, laboratory beagles feature consistent genetics, standardized diets and tightly controlled housing conditions.
On October 6, Biogerontology published a new collaborative study led by Professor Yuxuan Lyu (Southern University of Science and Technology), Academician Jian-Kang Zhu (Macau University of Science and Technology), Professor Baichuan Deng (South China Agricultural University), and Dr. Ming Li (Shanghai-Hong Kong Zhongke)[2]. The team carried out a full immune profiling survey on 80 beagles, mapping a comprehensive atlas of immune aging. They also ran head-to-head tests on three popular anti-aging strategies — and rapamycin pulled ahead, while calorie restriction delivered surprisingly modest short-term results. Our furry research helpers strike again!
Immune aging is not a simple downhill slide
While dogs share far more physiological and lifestyle similarities with humans than mice, earlier canine aging research had two major blind spots. First, most study dogs were spayed or neutered, removing sex hormone variables and erasing natural sex-difference data. Second, age grouping was overly simplistic, usually split only into “young” and “old”.
To generate findings with stronger relevance to human aging, this team avoided those pitfalls. They recruited 80 intact laboratory beagles, evenly split by sex and sorted into five distinct age groups. By measuring 17 routine blood parameters and 40 serum cytokines, they built a detailed timeline tracking how immunity shifts with age.
The data revealed that immune function does not decline steadily and smoothly as years pass.
Among immune-related blood cells, white blood cells, neutrophils and basophils did trend gradually downward with age. But this was not universal: lymphocytes and monocytes dropped in older groups, then unexpectedly rose again in the oldest cohort (10 years and above).
The 40 tested cytokines showed even more dynamic patterns. These molecules regulate inflammatory recruitment, tissue repair and matrix remodeling, each following its own unique schedule. In male dogs, IL-8 peaked in middle age; MMP-8 only surged at advanced old age. ErbB3 and Decorin, by contrast, kept falling consistently as the dogs grew older.
Every biomarker marched to its own rhythm. This proves age-related immune change is a sophisticated reprogramming process, not just a straightforward rule that “immunity gets weaker as you age”.
This non-linear pattern closely mirrors human immune senescence. A 2019 Nature Medicine paper showed human plasma proteins do not change at a constant rate across life, with clear inflection points around midlife[3]. Multi-omic tracking work in Nature Aging in 2024 reinforced this conclusion[4]. This beagle study adds another high-quality immune roadmap supporting the same idea.
Male and female dogs age on different immune timelines
Non-linear immune decline is already eye-opening, but sex emerged as another critical, often overlooked variable.
Roughly 10 cytokines showed statistically significant age-linked shifts in male dogs, including IL-13, TNF‑α and MCP‑1. Most peaked in old age and dipped again in the oldest group. Females only had two such cytokines: IL-13 hit its highest level in middle age, while IL-10 rose as they neared old age.
This tells us males and females follow distinct immune aging trajectories and rely on different core response pathways. Males experience broad, early swings in inflammatory cytokines, while female immune changes unfold more slowly and start later.
The non-linear nature of immune aging and these sex-specific curves make it clear there is no one-size-fits-all template for growing old. To test this newly drawn immune atlas, the researchers put three famous anti-aging candidates to the test and watched how they rewrote immune profiles.
Three star anti-aging interventions go head to head — and the gap is striking
Having mapped canine immune aging and confirmed its resemblance to human patterns, the team set out to answer a fascinating question: how do popular geroprotectors reshape immune aging in dogs? Rapamycin, canagliflozin and calorie restriction stepped onto the stage for this anti-aging showdown.
No.1 Rapamycin: The heavy hitter
It produced the broadest shift in cytokine levels of the three treatments. GM-CSF, IL-10, MCP‑1 and TNF‑α went down, while IFN‑γ, IL‑17A, IL‑21 and Trappin‑2 increased. To break this down simply: the downregulated factors are mostly tied to inflammatory recruitment and anti-inflammatory control, while the upregulated ones support targeted immune responses.
This mix of up and down regulation means rapamycin is far more than a simple anti-inflammatory drug. It rearranges the whole immune landscape, recalibrating separate immune pathways.
At Xi’an Springjia, we closely follow rapamycin-related immune research, as immune balance is a core pillar for developing functional nutrition ingredients that support healthy aging.
No.2 Canagliflozin: Quiet and mild
It barely moved the needle on routine blood work. Only three cytokines shifted: tissue-repair related Trappin‑2 rose slightly, while pro-inflammatory TNF‑α and immunomodulatory IL‑10 dipped a little. Overall, it delivered gentle anti-inflammatory tuning.
This effect was strongly sex-biased: changes stood out clearly in male dogs but were minimal in females. This lines up with prior mouse work, where canagliflozin only extended lifespan in male animals[5]. Its preference for male subjects appears inherent.
No.3 Calorie restriction: The surprise underperformer
The dogs on this regimen received 26% less energy every day. They lost noticeable weight, yet after 90 days, their blood and cytokine profiles were nearly identical to the control group. None of the 40 serum cytokines reached statistically significant differences, and no detectable shift appeared in peripheral immune markers.
Calorie restriction has been hyped for decades in human anti-aging circles, yet in dogs, 90 days only reliably produced weight loss. This is not a failure, though. The human CALERIE trial needed two years of consistent restricted eating before measurable peripheral immune changes showed up[6]. Calorie restriction may just be slow-acting.
Taken together, these three interventions create vastly different short-term immune signatures in young beagles. Rapamycin caused the most dramatic remodeling of the immune spectrum, canagliflozin brought subtle tweaks, and 90-day calorie restriction showed almost no immune response. Judging by immune aging markers alone, rapamycin won this round.
Still, we should not write off the others entirely. When it comes to human whole-body aging, the best intervention always depends on individual health background and goals.
Closing Thoughts
Our furry companions walk through a full aging journey in just 10 to 20 years, condensing the human 70–80 year aging timeline into a single pet lifetime. A puppy you bring home in your twenties may already grow old by the time you turn thirty. Their fleeting lives accelerate the progress of human anti-aging science.
Using beagles, the research team built a stage-specific, sex-aware map of immune aging and benchmarked three widely discussed geroprotectors. We cannot directly copy canine results onto humans, but the takeaway is clear: immune aging is not a steady downhill slope. Anti-aging interventions do not work universally. Sex and age bracket must always be factored in — and this framework applies directly to human aging research.
At Xi’an Springjia, we keep tracking these breakthroughs to guide our R&D of botanical extracts and nutritional raw materials that support balanced immunity and healthy longevity.
Someday, more discoveries may unlock interventions that extend healthy lifespan for humans and let our dogs stay with us a little longer. Right now, these beagles are our pioneers, paving the way.
After all, when we study aging, what we truly hope for is simple: to let every life we care about grow old more gently.
